Metraipolis › archive › dc_d40e7f29febc
Investigating the repurposing potential of immune checkpoint inhibition for cancer treatment using Mendelian randomisation — Europe PMC PPR:PPR1286973
- Source
- Europe PMC
- Original
- https://europepmc.org/article/PPR/PPR1286973
- DOI
- 10.21203/rs.3.rs-9656350/v1
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T14:13:23.998Z
- SHA-256 of the archived text
88468f1db9ad65d0dd401ed702260a417abbb50e2a112aa18814eee277c332c0- Stable URL of this page
https://metraipolis.com/documento/dc_d40e7f29febc
How to cite
Investigating the repurposing potential of immune checkpoint inhibition for cancer treatment using Mendelian randomisation — Europe PMC PPR:PPR1286973 — Europe PMC, https://europepmc.org/article/PPR/PPR1286973 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d40e7f29febc (Metraipolis archive dc_d40e7f29febc, sha256 88468f1db9ad65d0dd401ed702260a417abbb50e2a112aa18814eee277c332c0)
BibTeX
@misc{dcd40e7f29febc,
title = {Investigating the repurposing potential of immune checkpoint inhibition for cancer treatment using Mendelian randomisation — Europe PMC PPR:PPR1286973},
howpublished = {Europe PMC},
url = {https://europepmc.org/article/PPR/PPR1286973},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d40e7f29febc; sha256 88468f1db9ad65d0dd401ed702260a417abbb50e2a112aa18814eee277c332c0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/PPR/PPR1286973. Agents can read the archived copy with the MCP tool read_document.